Restart Life Secures Strategic Production Partner
Restart Life Sciences Corp. (NMLSD) has secured a strategic production partnership with a Canadian co-packer for manufacturing their Brain Balls product line. The co-packer, known for healthy cereals, will handle raw ingredients, packaging, and shipping from their British Columbia facility.
This partnership follows the December 13, 2024 joint venture with Brain Balls Inc. to develop health-focused products targeting cognitive performance and brain health. The company also completed a debt settlement of $118,476.75 by issuing 1,579,689 units at $0.075 per unit, each including one common share and one warrant exercisable at $0.10 for 12 months.
Additionally, Restart Life granted 1,830,000 stock options and 3,095,000 RSUs to officers, directors, and consultants, exercisable at $0.10 per share with a two-year term.
Restart Life Sciences Corp. (NMLSD) ha stabilito una partnership strategica per la produzione con un co-packer canadese per la realizzazione della loro linea di prodotti Brain Balls. Il co-packer, noto per i cereali salutari, si occuperà degli ingredienti grezzi, del confezionamento e della spedizione dalla loro struttura in British Columbia.
Questa partnership segue la joint venture del 13 dicembre 2024 con Brain Balls Inc. per sviluppare prodotti focalizzati sulla salute, mirati a migliorare le performance cognitive e la salute del cervello. L'azienda ha anche completato un accordo di debito di $118,476.75 emettendo 1,579,689 unità a $0.075 per unità, ciascuna comprendente una azione comune e un warrant esercitabile a $0.10 per 12 mesi.
Inoltre, Restart Life ha concesso 1,830,000 opzioni su azioni e 3,095,000 RSU a funzionari, direttori e consulenti, esercitabili a $0.10 per azione con un termine di due anni.
Restart Life Sciences Corp. (NMLSD) ha asegurado una asociación estratégica de producción con un co-packer canadiense para la fabricación de su línea de productos Brain Balls. El co-packer, conocido por sus cereales saludables, se encargará de los ingredientes crudos, el empaquetado y el envío desde su instalación en Columbia Británica.
Esta asociación sigue a la empresa conjunta del 13 de diciembre de 2024 con Brain Balls Inc. para desarrollar productos enfocados en la salud que apunten al rendimiento cognitivo y la salud cerebral. La compañía también completó un acuerdo de deuda de $118,476.75 emitiendo 1,579,689 unidades a $0.075 por unidad, cada una incluyendo una acción común y un warrant ejercitable a $0.10 durante 12 meses.
Además, Restart Life otorgó 1,830,000 opciones sobre acciones y 3,095,000 RSU a funcionarios, directores y consultores, ejercitables a $0.10 por acción con un plazo de dos años.
Restart Life Sciences Corp. (NMLSD)는 Brain Balls 제품 라인의 제조를 위해 캐나다의 공동 포장업체와 전략적 생산 파트너십을 체결했습니다. 건강한 시리얼로 알려진 이 공동 포장업체는 브리티시컬럼비아의 시설에서 원자재, 포장 및 배송을 담당할 것입니다.
이번 파트너십은 2024년 12월 13일에 Brain Balls Inc.와의 공동 투자 이후, 인지 성능과 뇌 건강을 목표로 하는 건강 중심 제품을 개발하기 위한 것입니다. 회사는 또한 $118,476.75의 채무 합의를 완료하였으며, 1,579,689 단위를 주당 $0.075에 발행하였고, 각 단위에는 하나의 보통주와 12개월 동안 $0.10에 행사할 수 있는 워런트가 포함되어 있습니다.
또한, Restart Life는 임원, 이사 및 컨설턴트에게 1,830,000 주식 옵션과 3,095,000 RSU를 부여하였으며, 주당 $0.10에 행사 가능하며 2년의 기간을 가집니다.
Restart Life Sciences Corp. (NMLSD) a sécurisé un partenariat stratégique de production avec un co-packer canadien pour fabriquer sa ligne de produits Brain Balls. Le co-packer, connu pour ses céréales saines, s'occupera des ingrédients bruts, de l'emballage et de l'expédition depuis son installation en Colombie-Britannique.
Ce partenariat fait suite à la coentreprise du 13 décembre 2024 avec Brain Balls Inc. pour développer des produits axés sur la santé ciblant la performance cognitive et la santé cérébrale. L'entreprise a également complété un règlement de dette de $118,476.75 en émettant 1,579,689 unités à $0.075 par unité, chacune incluant une action ordinaire et un bon de souscription exerçable à $0.10 pendant 12 mois.
De plus, Restart Life a accordé 1,830,000 options d'achat d'actions et 3,095,000 RSU à des dirigeants, directeurs et consultants, exerçables à $0.10 par action avec un terme de deux ans.
Restart Life Sciences Corp. (NMLSD) hat eine strategische Produktionspartnerschaft mit einem kanadischen Co-Packer für die Herstellung ihrer Brain Balls Produktlinie gesichert. Der Co-Packer, bekannt für gesunde Cerealien, wird die Rohstoffe, die Verpackung und den Versand von seiner Einrichtung in British Columbia übernehmen.
Diese Partnerschaft folgt dem Joint Venture vom 13. Dezember 2024 mit Brain Balls Inc., um gesundheitsorientierte Produkte zu entwickeln, die auf kognitive Leistung und Gehirngesundheit abzielen. Das Unternehmen hat auch eine Schuldentlastung in Höhe von $118,476.75 durch die Ausgabe von 1,579,689 Einheiten zu je $0.075 pro Einheit abgeschlossen, wobei jede Einheit eine Stammaktie und ein Warrant enthält, der für 12 Monate zu $0.10 ausgeübt werden kann.
Zusätzlich hat Restart Life 1,830,000 Aktienoptionen und 3,095,000 RSUs an Führungskräfte, Direktoren und Berater gewährt, die zu $0.10 pro Aktie mit einer Laufzeit von zwei Jahren ausgeübt werden können.
- Strategic production partnership secured with established Canadian health food co-packer
- Manufacturing facility ready for Brain Balls production in British Columbia
- Debt settlement completed, reducing company liabilities by $118,476.75
- Dilution of shareholder value through debt settlement share issuance
- Additional dilution from 1.83M stock options and 3.095M RSUs granted
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to announce that the Company has secured a strategic production partnership with a Canadian co-packer. This new strategic partnership follows the press release dated December 13, 2024, where Restart Life and Brain Balls Inc. formed a Joint Venture to bring health-focused products to market, targeting cognitive performance, mental clarity, and overall brain health.
With this agreement, the co-packer, a recognized leader in the health food industry, will serve as the official production partner for the Brain Balls and subsequent product lines. The co-packer operates a fully equipped production facility in British Columbia, Canada, which will be utilized to handle raw ingredients, package and ship, ensuring the highest quality standards for consumers.
The co-packer, known for its flagship branded healthy cereals, has demonstrated a proven track record of success in the production and distribution of health-conscious, clean-label food products. Their production capabilities, combined with their expertise in delivering high-quality products, make them an ideal partner for Restart Life.
"We are thrilled to have this co-packer as our strategic production partner," said Steve Loutskou, CEO of Restart Life Sciences. "Their established reputation, production facility, and history of success in the health food sector make them the perfect fit for Restart. We look forward to bringing our innovative products to market and addressing the growing demand for health-focused foods."
The co-packers' expertise will ensure that the Brain Balls product line is produced in a facility that meets the highest standards of quality and safety. This partnership also opens up exciting opportunities to further expand distribution to new markets, both in Canada and abroad.
Restart Life's CEO plans to visit the co-packer's facility to engage in further discussions and strengthen the collaboration. This visit is also timed to coincide with the Company's participation in Canada's leading trade show for natural, organic, and wellness consumer packaged goods, where it aims to broaden its network and explore new business opportunities.
Further to its news release dated Feb 7, 2025, Restart Life has closed a debt settlement transaction to settle an aggregate
The Debt Settlement shall constitute a "related party transaction" as defined under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying on the exemptions under section 5.5(a) and section 5.7(1)(a) from the formal valuation and minority shareholder approval requirements of MI 61-101, as the fair market value of the shares issued to the related party does not exceed
In addition, the Company has granted an aggregate 1,830,000 incentive stock options ("the Options") and 3,095,000 restricted share units (the "RSUs") to officers, directors and consultants of the Company. The Options and RSUs are valid for a two year term and the Options are exercisable at a price
Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
On behalf of the board of directors
Chief Executive Officer - Steve Loutskou
Tel: +1 (778) 819-0244
Email: hello@restartlife.co
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/241436
FAQ
What is the strategic partnership announced by Restart Life Sciences (NMLSD) in February 2025?
How much debt did Restart Life Sciences (NMLSD) settle in February 2025?
How many stock options and RSUs did Restart Life Sciences (NMLSD) grant in February 2025?
What is the exercise price and expiry period for the warrants issued in NMLSD's February 2025 debt settlement?
